JENNIFER PEMBERTON: Open Payments
NPI 1932487741 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 22 payments from 7 companies in 2025. Trend: 2023 $809 · 2024 $2,116 · 2025 $1,379
Travel & lodging: $853Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 9 | $1,083 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| PFIZER INC. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $15 |
Products named: LINQ II, LEQVIO, JARDIANCE, MICRA, ELIQUIS, VERQUVO, OPSUMIT, REPATHA.
Industry payments across TX — which companies pay providers there.
